Your browser is no longer supported. Please, upgrade your browser.
Settings
IBB iShares Nasdaq Biotechnology ETF daily Stock Chart
IBB [NASD]
iShares Nasdaq Biotechnology ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-0.60%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-1.98%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter0.21%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio6.31 Perf Half Y3.26%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year5.63%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range240.30 - 303.74 Perf YTD9.47%
Dividend0.61 P/FCF- EPS past 5Y- ROI- 52W High-4.35% Beta-
Dividend %0.21% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low20.90% ATR3.63
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)45.87 Volatility1.06% 1.18%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.76 Prev Close291.16
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume993.82K Price290.52
Recom- SMA20-1.11% SMA50-0.68% SMA2002.26% Volume756,059 Change-0.22%
May-25-17 10:36AM  Could There Be a Revenue Fall for Neulasta in 2017? Market Realist
09:52AM  Alexion Pharmaceuticals: Time to Buy? Barrons.com
May-23-17 01:17PM  What To Make Of the Alexion Shake-up Investopedia
10:54AM  Winners And Losers From Trump's $4 Trillion Budget Proposal Benzinga
May-22-17 02:30PM  Amgen's Woes: It Could Always Be Worse! Investopedia
May-18-17 02:02PM  Will Biotech Ever Move Higher? Investopedia
01:08PM  Are Stock Returns during Summer Months That Bad? Market Realist
May-17-17 05:37PM  The Latest Market Trends Every Biopharma Investor Needs to Know Zacks
01:16PM  Calm Down, People! Over-Reacting to Equity Markets Investopedia
May-16-17 07:59AM  Bill Gates tells new grads to read this book that says the world is getting better MarketWatch
May-12-17 09:44AM  Will US Markets Continue to Surge in 2Q17? Market Realist
08:49AM  Biotech Stocks Are Cheap The Wall Street Journal
May-11-17 03:52PM  Biotech ETFs Sink After House Passage of Health-Care Bill The Wall Street Journal
03:20PM  Senate Needs To Move Fast On Healthcare Before Overhauling Tax Code Benzinga
May-08-17 01:29PM  KITE Plunges, Take Sector With It Investopedia
May-05-17 12:07PM  Here are two great reasons to buy biotech: Technician CNBC
May-04-17 04:09PM  A Biotech Warning Sign? Barrons.com
May-02-17 01:15PM  Amgen's rough couple of days CNBC Videos
Apr-28-17 05:01PM  Trump's first 100 days, now what? CNBC Videos
05:00PM  5 trades for the next 100 days CNBC Videos
Apr-27-17 05:16PM  Mixed bag for biotech earnings CNBC Videos
Apr-25-17 10:22AM  Biogen: Stuck in a Rut? Barrons.com
08:58AM  Biogen's Excellent Q1 Bodes Well for Biotech Investopedia
08:26AM  Earnings Preview: What To Expect From Amgen On Wednesday Forbes
Apr-13-17 05:58PM  Final Trade: C, IWM & more CNBC Videos
05:00PM  The next billion dollar drugs: 3 trades CNBC Videos
01:53PM  Health Care and Technology: A Perfect Combo for Stock Investors Now? Zacks
Apr-12-17 05:11PM  Beyond Trump, markets primed for pullback: Strategist CNBC Videos
Apr-06-17 01:16PM  Biotech: The Canary in the Coal Mine Investopedia
Apr-04-17 12:24PM  There's Value in Healthcare ETFs Investopedia
Mar-31-17 01:18PM  About that GOP health reform, it was no big deal for health-care stocks in the first quarter CNBC
Mar-29-17 08:32AM  These Charts Suggest Biotech Is Heading Higher Investopedia
Mar-28-17 05:00PM  5 ways to trade today's market rally CNBC Videos
Mar-27-17 05:33PM  Biotech Stocks Strong In Weak Market Investopedia
05:00PM  Trading a losing streak: 6 plays CNBC Videos
01:56PM  Here's who has the most to lose if the government starts negotiating drug prices Business Insider
Mar-24-17 04:46PM  Stock Market Video Analysis Wk Ending 3/24/17
04:35PM  Market Shakes As Republicans Accept Defeat On Healthcare Bill Benzinga
09:28AM  The Market In 5 Minutes Benzinga
Mar-23-17 01:22PM  Stalling Healthcare Reform May Be Holding Up the Rally
10:57AM  Biotechs Back in the Doghouse After Failed Rally at Investopedia
10:06AM  Health Care Vote Looms With Market Focused On Possible Tax Policy Implications
Mar-22-17 09:58AM  And Along Came A Spider...With Potential Benefits For Stroke Victims
09:30AM  Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma, Celgene and Amgen
Mar-21-17 05:02PM  Trump goes to the Hill, stocks slammed
04:28PM  Stock Market Video Analysis 3/21/17
10:57AM  Biotech Momentum Outweighs Pharma 'Red Flag' In ETF Upgrade
10:43AM  Trump says he wants to tackle drug pricing in the GOP's Obamacare replacement plan
07:00AM  Biotech Bull Making a Comeback
Mar-19-17 10:04PM  How Much You'd Spend On Healthcare Under New GOP Plan, By Income
01:21PM  Businesses Will Be Impacted By Trumpcare
Mar-17-17 01:43PM  The Top 4 ETFs to Track the Nasdaq in 2017 at Investopedia
Mar-15-17 04:36PM  Stock Market Video Analysis
08:26AM  Biotech is Bubbling Up
Mar-13-17 05:46PM  Time to Buy Biotech ETFs?
02:08PM  Biotech stocks are turning bullishhere's how to profit
12:23PM  Pres. Trump nominates Dr. Scott Gottlieb to run FDA
Mar-10-17 04:54PM  Stock Market Video Analysis
11:32AM  Adam Feuerstein Talks Vulnerable Pharmaceuticals, Drug Pricing Under Trump
Mar-09-17 05:14PM  Biotech Reporter Adam Feuerstein Will Be On Benzinga's PreMarket Prep Friday Morning
01:25PM  What Does Gilead Need? Stable HCV Scripts and "a String of Pearls" at Barrons.com
11:51AM  GOP Health Plan: Winners, Losers & Who Knows at Barrons.com
08:00AM  Trending: Aerospace and Defense Advance as Trump Promises Military Spending Boost
Mar-07-17 05:07PM  3 large-cap buys to play strength in health care: Ross
05:00PM  5 ways to trade health care after AHC unveil
03:21PM  Analysts Scratch Their Heads Over Trump Drug Price Tweet at The Wall Street Journal
01:05PM  Analyst: Not 'worst case scenario' for drug industry
12:11PM  Drug innovators will continue to do well: Isaly
11:32AM  Healthcare Stocks Fall, But Still Appear Strong at Investopedia
10:37AM  Will Obamacare Repeal Make Healthcare Stocks Sick? at Barrons.com
09:48AM  Trump's Latest Drug Pricing Tweet Hits Biotech Stocks at The Wall Street Journal
09:18AM  Trump tweets that he's working on a 'new system where there will be competition in the drug industry'
Mar-01-17 07:00PM  Trades to make following Trump's speech at CNBC
05:32PM  Did Biotech Get a Presidential Pardon? at Barrons.com
05:15PM  Drugs stocks shrug off Trump warning
05:00PM  8 trades following Trump's congressional speech
12:46PM  Infrastructure, Immigration And 7 Key Takeaways From Trump's Address To Congress
11:55AM  Gilead Sciences: M&A to the Rescue? at Barrons.com
Feb-28-17 02:17PM  Kite CEO: May see cancer drug approval by end of year
02:14PM  Two biotechs taking it on the chin
09:09AM  Alnylam Pharmaceuticals Advances Its Patisiran Research Program
Feb-27-17 04:25PM  Market Action Shifts, but Only Slightly
03:38PM  Biotech Surges. Is the Sector Breaking Out? at Investopedia
Feb-24-17 04:13PM  Heres how analysts say you should trade Trumps speech to Congress at MarketWatch
12:54PM  8 Signs the Trump Trade Is Crumbling at The Wall Street Journal
Feb-21-17 05:21PM  [$$] Why Biotech Stocks Are Finally Set to Break Out at Barrons.com
Feb-19-17 05:15PM  Barron's Picks And Pans: General Motors, Hess, Biotechs And More
Feb-17-17 04:35PM  Stock Market Video Analysis 2/17/17
11:34AM  Biotech ETF Investors are Still on the Sidelines at Investopedia
07:37AM  Prolia Expected to Be a Significant Growth Driver for Amgen in 2017
Feb-15-17 05:19PM  Biotech boom?
04:31PM  Stock Market Video Analysis 2/15/17
02:44PM  Two Great Stock Ideas in the IBB Biotech ETF at Investopedia
09:44AM  Gilead Sciences: Its Game to Lose? at Barrons.com
Feb-14-17 03:07PM  The New Normal: Is The Current Bull Market Trump Resistant?
Feb-13-17 05:58PM  Final Trade: QCOM, TWTR & more
Feb-10-17 10:17AM  Why Gilead's Disastrous Forecast is Good News for Biotech at Barrons.com
Feb-08-17 05:45PM  Gilead tanks on weak forecast
04:00PM  How To Maximize Biotech Returns Under Donald Trump at Forbes
01:28PM  Gilead: Where's the Bottom? at Barrons.com
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.